4065Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial. (28th August 2018) - Hopley, C W; Kavanagh, S; Patel, M; Baumgartner, I; Berger, J S; Blomster, J I; Fowkes, F G R; Jones, W S; Katona, B G; Mahaffey, K W; Norgren, L; Held, P; et al.